PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA. Electronic address: ats114@stanford.edu.\', \'Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.\', \'Medical Service, VA Palo Alto Health Care System, Palo Alto, CA.\', \'Division of Cardiology, Kaiser Permanente, Santa Clara, CA.\', \'Medical Service, VA Palo Alto Health Care System, Palo Alto, CA; Center for Health Policy and Primary Care and Outcomes Research, Department of Medicine, Stanford, CA.\', \'Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA; Medical Service, VA Palo Alto Health Care System, Palo Alto, CA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0002-8703(21)00151-410.1016/j.ahj.2021.06.004
?:hasPublicationType
?:journal
  • American heart journal
is ?:pmid of
?:pmid
?:pmid
  • 34126079
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.267
?:rankingScore_hIndex
  • 169
is ?:relation_isRelatedTo_publication of
?:title
  • Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran\'s affairs healthcare system.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all